# Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study

> **NCT05452187** · — · COMPLETED · sponsor: **Hospital Mutua de Terrassa** · enrollment: 79 (actual)

## Conditions studied

- Inflammatory Bowel Diseases
- Hepatitis C Virus Infection

## Interventions

- **DRUG:** Assess the effectiveness and safety of DAAs in patients with IBD.
- **DRUG:** Evaluate the interaction of DAAs with IBD drugs, particularly immunosuppressants and/or biologics.
- **OTHER:** Assessment of the impact of DAAs on the course of IBD.

## Key facts

- **NCT ID:** NCT05452187
- **Lead sponsor:** Hospital Mutua de Terrassa
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-12
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-12-20
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2022-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05452187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05452187, "Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05452187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*